Processa Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount
Processa Pharmaceuticals, Inc. (PCSA) reported Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount of -$315.31 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes · last filed 2026-03-18
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, state and local income taxes, amount for fiscal 2025 was -$315.31K.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, state and local income taxes, amount for fiscal 2024 was -$494.14K.
| Period end | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount 12 month |
|---|---|
| 2025-12-31 | -$315.31K 10-K · filed 2026-03-18 |
| 2024-12-31 | -$494.14K 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |